Duvall Diantha
CHIEF FINANCIAL OFFICER at GENOCEA BIOSCIENCES, INC.; Chief Accounting Officer at Bioverativ Inc.
- Sold, on record
- $56k
- Dollars the filings state
- Form 4 sales
- 5
- Latest Jun 2, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- GENOCEA BIOSCIENCES, INC.CHIEF FINANCIAL OFFICER
- Bioverativ Inc.Chief Accounting Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- GENOCEA BIOSCIENCES, INC.29,598 shares
- Bioverativ Inc.818 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Bioverativ Inc.UnusualJun 28, 2017 2017
Sold 818 shares at $60.47 ($49k)
Duvall Diantha, Chief Accounting Officer
Sold 27.8% of holdings ($178k position)2,128 shares leftFirst sale on recordFiling
- 2 Form 4 sale GENOCEA BIOSCIENCES, INC.Plan not statedMar 16, 2022 +1722 days
Sold 2,873 shares at $1.10 ($3k)
Duvall Diantha, CHIEF FINANCIAL OFFICER
Sold 3% of holdings ($105k position)92,738 shares leftFirst sale on recordFiling
- 3 Form 4 sale GENOCEA BIOSCIENCES, INC.Plan not statedApr 4, 2022 +19 days
Sold 963 shares at $1.25 ($1k)
Duvall Diantha, CHIEF FINANCIAL OFFICER
Sold 1% of holdings ($116k position)91,775 shares leftFiling
- 4 Form 4 sale GENOCEA BIOSCIENCES, INC.Plan not statedMay 26, 2022 +52 days
Sold 24,407 shares at $0.0800 ($2k)
Duvall Diantha, CHIEF FINANCIAL OFFICER
Sold 24.1% of holdings ($8k position)76,743 shares leftFiling
- 5 Form 4 sale GENOCEA BIOSCIENCES, INC.Plan not statedJun 2, 2022 +7 days
Sold 1,355 shares at $0.0600 ($81)
Duvall Diantha, CHIEF FINANCIAL OFFICER
Sold 1.8% of holdings ($5k position)75,388 shares left0.5x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2022 | Jun 3, 2022 | GENOCEA BIOSCIENCES, INC. | CHIEF FINANCIAL OFFICER | Form 4 sale | 1,355 | $81 | 1.8% | Plan not stated | SEC |
| May 26, 2022 | May 26, 2022 | GENOCEA BIOSCIENCES, INC. | CHIEF FINANCIAL OFFICER | Form 4 sale | 24,407 | $2k | 24.1% | Plan not stated | SEC |
| Apr 4, 2022 | Apr 5, 2022 | GENOCEA BIOSCIENCES, INC. | CHIEF FINANCIAL OFFICER | Form 4 sale | 963 | $1k | 1.0% | Plan not stated | SEC |
| Mar 16, 2022 | Mar 17, 2022 | GENOCEA BIOSCIENCES, INC. | CHIEF FINANCIAL OFFICER | Form 4 sale | 2,873 | $3k | 3.0% | Plan not stated | SEC |
| Jun 28, 2017 | Jun 29, 2017 | Bioverativ Inc. | Chief Accounting Officer | Form 4 sale | 818 | $49k | 27.8% | Unusual | SEC |